140 related articles for article (PubMed ID: 30343713)
1. Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC).
Janmohamed A; Trivedi PJ
Best Pract Res Clin Gastroenterol; 2018; 34-35():71-83. PubMed ID: 30343713
[TBL] [Abstract][Full Text] [Related]
2. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.
Trivedi PJ; Lammers WJ; van Buuren HR; Parés A; Floreani A; Janssen HL; Invernizzi P; Battezzati PM; Ponsioen CY; Corpechot C; Poupon R; Mayo MJ; Burroughs AK; Nevens F; Mason AL; Kowdley KV; Lleo A; Caballeria L; Lindor KD; Hansen BE; Hirschfield GM;
Gut; 2016 Feb; 65(2):321-9. PubMed ID: 25567117
[TBL] [Abstract][Full Text] [Related]
3. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
[TBL] [Abstract][Full Text] [Related]
4. Toward precision medicine in primary biliary cholangitis.
Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF
Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985
[TBL] [Abstract][Full Text] [Related]
5. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.
Rong G; Wang H; Bowlus CL; Wang C; Lu Y; Zeng Z; Qu J; Lou M; Chen Y; An L; Yang Y; Gershwin ME
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):132-41. PubMed ID: 25762349
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in primary biliary cirrhosis.
Farinati F; Floreani A; De Maria N; Fagiuoli S; Naccarato R; Chiaramonte M
J Hepatol; 1994 Sep; 21(3):315-6. PubMed ID: 7530737
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Epidemiology of Primary Biliary Cholangitis.
Lleo A; Colapietro F
Clin Liver Dis; 2018 Aug; 22(3):429-441. PubMed ID: 30259845
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis.
Caballería L; Parés A; Castells A; Ginés A; Bru C; Rodés J
Am J Gastroenterol; 2001 Apr; 96(4):1160-3. PubMed ID: 11316164
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists.
Trivedi PJ; Corpechot C; Pares A; Hirschfield GM
Hepatology; 2016 Feb; 63(2):644-59. PubMed ID: 26290473
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of symptomatic primary biliary cirrhosis initially complicated with esophageal varices.
Murata Y; Abe M; Furukawa S; Kumagi T; Matsui H; Matsuura K; Matsuura B; Hiasa Y; Onji M
J Gastroenterol; 2006 Dec; 41(12):1220-6. PubMed ID: 17287902
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
Macaron C; Hanouneh IA; Zein NN
Hepatology; 2010 Dec; 52(6):2239; author reply 2239-40. PubMed ID: 21105115
[No Abstract] [Full Text] [Related]
14. Primary biliary cirrhosis and hepatocellular carcinoma.
Findor J; He XS; Sord J; Terg R; Gershwin ME
Autoimmun Rev; 2002 Aug; 1(4):220-5. PubMed ID: 12848999
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers.
Floreani A; Mangini C; Reig A; Franceschet I; Cazzagon N; Perini L; Caballería L; Cocchio S; Baldo V; Parés A
Am J Gastroenterol; 2017 Jan; 112(1):114-119. PubMed ID: 27779196
[TBL] [Abstract][Full Text] [Related]
16. [Good prognosis in asymptomatic primary biliary cirrhosis].
Lööf L; Lindgren S
Lakartidningen; 2010 May 26-Jun 1; 107(21):1396-8. PubMed ID: 20645617
[No Abstract] [Full Text] [Related]
17. Bile acids and the Risk for Hepatocellular Carcinoma in Primary Biliary Cholangitis.
Altamirano-Barrera A; Uribe M; Lammert F; Méndez-Sánchez N
Ann Hepatol; 2016; 15(3):453-4. PubMed ID: 27049502
[No Abstract] [Full Text] [Related]
18. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history.
Sylvestre PB; Batts KP; Burgart LJ; Poterucha JJ; Wiesner RH
Liver Transpl; 2003 Oct; 9(10):1086-93. PubMed ID: 14526404
[TBL] [Abstract][Full Text] [Related]
19. [What is the risk of developing hepatocarcinoma in primary biliary cirrhosis?].
Vivas S; Palacio MA; Linares A; Rodrigo L
Gastroenterol Hepatol; 1997; 20(7):383. PubMed ID: 9377239
[No Abstract] [Full Text] [Related]
20. Hepatocellular carcinoma in primary biliary cirrhosis: an autopsy study.
Nakanuma Y; Terada T; Doishita K; Miwa A
Hepatology; 1990 Jun; 11(6):1010-6. PubMed ID: 1694811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
